Contemporary state of the art percutaneous coronary intervention techniques offer treatment strategies and solutions to an increasing number of patients with heart failure and complex coronary artery disease. Percutaneous mechanical circulatory support is intended to alleviate the mechanical and energetic workload imposed to a failing ventricle by reducing left ventricle pressures and volumes and potentially also increasing coronary blood flow. The PulseCath iVAC2L is a transaortic left ventricular assist device that applies a pneumatic driving system to produce pulsatile forward flow. Herein, the essential aspects regarding iVAC2L are discussed with focus on its mechanisms of action and the available clinical experience.

coronary disease, heart failure, high-risk percutaneous coronary interventions, mechanical circulatory support, PulseCath iVAC2L
dx.doi.org/10.2217/fca-2019-0060, hdl.handle.net/1765/125366
Future Cardiology
no subscription
Erasmus MC: University Medical Center Rotterdam

Bastos, M.B. (Marcelo B.), van Wiechen, M.P. (Maarten P.), & van Mieghem, N.M. (2020). PulseCath iVAC2L: next-generation pulsatile mechanical circulatory support. Future Cardiology, 16(2), 103–112. doi:10.2217/fca-2019-0060